domperidone has been researched along with Sleep Initiation and Maintenance Disorders in 2 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnulf, I | 1 |
Konofal, E | 1 |
Gauthier, C | 1 |
Chedru, F | 1 |
Rampello, L | 1 |
Raffaele, R | 1 |
Nicoletti, G | 1 |
Le Pira, F | 1 |
Vecchio, I | 1 |
Malaguarnera, M | 1 |
Drago, F | 1 |
1 trial available for domperidone and Sleep Initiation and Maintenance Disorders
Article | Year |
---|---|
Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactin.
Topics: Adult; Anorexia; Antiemetics; Cimetidine; Domperidone; Female; Histamine H2 Antagonists; Humans; Mal | 1997 |
1 other study available for domperidone and Sleep Initiation and Maintenance Disorders
Article | Year |
---|---|
Severe restless legs syndrome presenting as intractable insomnia.
Topics: Chronic Disease; Domperidone; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, D | 2004 |